2019 Research With Cannabis Sativa and Lymphoma Cells

2019 Research With Cannabis Sativa and Tcells

Synergistic Cytotoxic Activity of Cannabinoids from Cannabis sativa Extracts on T Cells Associated with Cutaneous T Cell Lymphoma Cell Lines


MedC’s and AgMedica’s recognition represents a significant milestone for the Company as it seeks to expand the identification and development of clinically-validated cannabis-derived medicines that can provide substantiated health and wellness benefits – particularly related to oncology.

This research is in process: For further information: For media or other inquiries, please contact: AgMedica Bioscience Inc., Sengkee Ahn, MBA, FEA, Vice President, Investor Relations and International Business Development, P: 1-844-247-4633, E: info@AgMedica.ca

Leave a Reply

Your email address will not be published. Required fields are marked *